Skip to content
Screener

Inspire Medical Systems INSP Q3 2025 earnings

Reported November 3, 2025 · After market close

Revenue$224.5MMiss by $37.8M
EPS$0.38Beat by $0.53
Revenue estimate$262.3M
EPS estimate-$0.15

Next report

Nov 2, 2026 (in a month)
Revenue estimate$204.2M
EPS estimate$0.11

Financials

Q3 2025

Income statement

See full
Revenue$224.5M+10.5%
Gross profit$192.7M+12.8%
Operating income$9.6M-32.6%
Net income$9.9M-46.3%
EPS (diluted)$0.34-43.3%

Balance sheet

See full
Cash & equivalents$112.8M-23.5%
Total debt$32.6M+28.6%
Total equity$666.5M-4.3%
Total assets$807.7M+1.4%

Cash flow

See full
Operating cash flow$68.5M+31.1%
CapEx$10.4M+30.4%
Free cash flow$58.1M+31.2%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$2.19B-65.0%
Enterprise value$2.11B-65.6%
P/E49.3×—
P/S2.5×-5.8×

Profitability

See full
Gross margin84.9%+0.1pp
Operating margin4.2%—
Net margin5%—
FCF margin11.2%+6.1pp

Returns & leverage

See full
Return on equity6.5%—
Debt / equity0×0.0×
Current ratio5.3×-2.6×

Segments

By segment

See full
Operating Segment$224.5M+10.5%

FAQ

When did Inspire Medical Systems report Q3 2025 earnings?
Inspire Medical Systems (INSP) reported Q3 2025 earnings on November 3, 2025 after market close.
What were Inspire Medical Systems's Q3 2025 revenue and EPS?
Inspire Medical Systems reported revenue of $224.5M and eps of $0.38 for Q3 2025.
Did Inspire Medical Systems beat estimates in Q3 2025?
Revenue missed the consensus estimate of $262.3M by $37.8M. EPS beat the consensus estimate of $-0.15 by $0.53.
How did Inspire Medical Systems's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.5% from $203.2M a year earlier and eps declined 36.7% from $0.60.
Where can I find Inspire Medical Systems's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001609550-25-000052) and the 10-Q periodic report (0001609550-25-000053) directly on SEC EDGAR. The filing index links above go to sec.gov.